Trial site
Atlanta Diabetes Associates
Atlanta, Georgia 30318, United StatesNot linked to an institution yet
- 14running trials
- 13closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Phase
- Phase 310 trials
- Phase 25 trials
- Phase 41 trial
- Status
- Completed12 trials
- Active, not recruiting9 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Medtronic MiniMed, Inc.5 trials
- Novo Nordisk A/S5 trials
- Eli Lilly and Company3 trials
- Senseonics, Inc.2 trials
- vTv Therapeutics2 trials
- and 10 more
Running trials
Recruiting
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
NCT07864168· Medtronic MiniMed, Inc.· Source
Contact: Research Admin
Recruiting
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
NCT07616206· Phase 2· vTv Therapeutics· Source
Contact: Bruce W Bode, MD (principal investigator)
Active, not recruiting
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity
NCT07575932· Phase 2· Pfizer· Source
Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NCT07521475· Insulet Corporation· Source
Contact: Amanda Maxson
Recruiting
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
NCT07296276· i-SENS, Inc.· Source
Contact: Amanda Maxson Clinical Research Manager, RN
Active, not recruiting
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
NCT07228117· Medtronic MiniMed, Inc.· Source
Active, not recruiting
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
NCT07076199· Phase 3· Novo Nordisk A/S· Source
Active, not recruiting
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
NCT06914895· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
NCT06334133· Phase 3· vTv Therapeutics· Source
Active, not recruiting
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
NCT06383390· Phase 3· Eli Lilly and Company· Source
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
NCT05762107· Phase 2· Zucara Therapeutics Inc.· Source
Contact: Amanda Maxson
Active, not recruiting
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
NCT05330325· Phase 3· Novo Nordisk A/S· Source
Active, not recruiting
Eversense® Non-adjunctive Use Post Approval Study
NCT04836546· Senseonics, Inc.· Source
Active, not recruiting
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
NCT03811561· Phase 3· Novo Nordisk A/S· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
Description of Patients With Type 1 Diabetes Treated With Teplizumab
NCT06892002· Sanofi· Source
Recruiting
A Study of Pitolisant in Patients With Prader-Willi Syndrome
NCT06366464· Phase 3· Harmony Biosciences Management, Inc.· Source
Contact: Ann Adee
Completed
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
NCT06269107· Phase 3· Novo Nordisk A/S· Source
Completed
The True Vie I3 Continuous Glucose Monitoring System in Pediatric Patients With Type 1 Diabetes Mellitus
NCT05908448· Sinocare· Source
Completed
Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec
NCT06238778· Phase 2· Diasome Pharmaceuticals· Source
Completed
A Study of CT-868 in Type 1 Diabetes Mellitus
NCT06062069· Phase 2· Carmot Therapeutics, Inc.· Source
Completed
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
NCT05904743· Phase 4· Mannkind Corporation· Source
Completed
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
NCT05714059· Medtronic MiniMed, Inc.· Source
Completed
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®
NCT05224258· Medtronic MiniMed, Inc.· Source
Completed
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
NCT05238142· Medtronic MiniMed, Inc.· Source
Completed
A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
NCT04865770· Phase 3· Novo Nordisk A/S· Source
Completed
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
NCT04255433· Phase 3· Eli Lilly and Company· Source
Completed
Post Approval Study of the Eversense® Continuous Glucose Monitoring
NCT03908125· Senseonics, Inc.· Source
Report an error